(Q34072112)

English

The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

multiple sclerosis

0 references

author name string

Karsten Beer

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Martin Müller

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Anna Marie Hew-Winzeler

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Adriano Bont

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Philippe Maire

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Xiaojun You

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pamela Foulds

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jessica Mårlind

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Daniela Curtius

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

10 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

144

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2377-11-144

0 references

Management strategies for improving the tolerability of interferons in the treatment of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227610

5 July 2018

Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227610

5 July 2018

A post-marketing study on interferon beta 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227610

5 July 2018

Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227610

5 July 2018

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3227610

5 July 2018

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-144

21 January 2018

Stopping beta-interferon therapy in multiple sclerosis: an analysis of stopping patterns

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22074056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2377-11-144

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34072112&oldid=1752403626"